drugset / Trial / NCT01570478
A Study in Patients With Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the present study is to demonstrate the higher efficacy of Foster® NEXThaler® 100/6 extra fine (two inhalations b.i.d.) versus Seretide® Accuhaler® 250/50 (one inhalation b.i.d.), in terms of pulmonary function (change from baseline to the end of treatment in post-dose peripheral airway resistance) in patients with asthma.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone | Small molecule | 400 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 500 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 24 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 100 ug | Inhaled |